Cargando…

The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis

BACKGROUND: Asymptom of invasive candidiasis (IC) and low positive rate of blood culture lead to delay diagnose of neonatal infection. Serum (1,3)-β-D-glucan (BDG) performs well in adult IC, but its use in neonatal IC is unclear. We evaluated the use of BDG, procalcitonin (PCT), high-sensitive C-rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Junfei, Wu, Yongbing, Lai, Weiming, Lu, Weiming, Mu, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692940/ https://www.ncbi.nlm.nih.gov/pubmed/31412796 http://dx.doi.org/10.1186/s12879-019-4364-x

Ejemplares similares

Clinical Characteristic and Pathogen Spectrum of Neonatal Sepsis in Guangzhou City from June 2011 to June 2017
por: Guo, Junfei, et al.
Publicado: (2019)

Change of serum lipoproteins and its potential use in stratifying patients with sepsis among neonates
por: Guo, Junfei, et al.
Publicado: (2023)

Rapid identification of Brucella sepsis/osteomyelitis in a 6-year old febrile patient with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry directly from positive blood culture: a case report
por: Guo, Junfei, et al.
Publicado: (2019)

360. The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
por: Son, Hyo-Ju
Publicado: (2022)

(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Letter on “(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial”
por: Kritikos, Antonios, et al.
Publicado: (2021)

Systemic neonatal candidiasis.
por: Reid, M., et al.
Publicado: (1991)

Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates
por: Mackay, Cheryl Anne, et al.
Publicado: (2011)

β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model
por: Khodadadi, Hossein, et al.
Publicado: (2014)

Experience with β-d-Glucan Assay for Diagnosis of Invasive Candidiasis in ICU Patients: Pilot Study from India
por: Bansal, Nitin, et al.
Publicado: (2017)

Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates
por: Hsu, Jen-Fu, et al.
Publicado: (2018)

The Diagnostic Value of Brush Cytology Alone and in Combination with Tumor Markers in Pancreaticobiliary Strictures
por: Kuzu, Ufuk Barış, et al.
Publicado: (2015)

Diagnostic Value of Inflammatory Markers and Cytokines in Neonatal Sepsis
por: Wu, Lijie, et al.
Publicado: (2022)

Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?
por: Eggimann, Philippe, et al.
Publicado: (2011)

Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study
por: Bansal, Nitin, et al.
Publicado: (2018)

Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis
por: Murri, Rita, et al.
Publicado: (2021)

Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study)
por: Ramos, Jose Tomas, et al.
Publicado: (2017)

Neonatal thrush of newborns: Oral candidiasis?
por: Vainionpää, Anne, et al.
Publicado: (2019)

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
por: Hanson, Kimberly E., et al.
Publicado: (2012)

Utility of Serial β-d-Glucan Levels in Patients with High Risk for Invasive Candidiasis: A Potential Tool for Antifungal Stewardship
por: Chua, Alvin Qijia, et al.
Publicado: (2017)

Retracted: Diagnostic Value of Inflammatory Markers and Cytokines in Neonatal Sepsis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Diagnostic Performance of 1→3-β-d-Glucan in Neonatal and Pediatric Patients with Candidemia
por: Montagna, Maria Teresa, et al.
Publicado: (2011)

Diagnostic performance of the (1–3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers
por: Son, Hyo-Ju, et al.
Publicado: (2017)

Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3‐beta‐D‐glucan in immunocompromised patient suspected fungal infection
por: Susianti, Hani, et al.
Publicado: (2021)

Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences
por: Clancy, Cornelius J., et al.
Publicado: (2018)

Evaluation of Diagnostic Value of Procalcitonin as a Marker of Neonatal Bacterial Infections
por: Monsef, Alireza, et al.
Publicado: (2012)

Invasive candidiasis and candidemia in pediatric and neonatal patients: A review of current guidelines
por: Vasileiou, Eleni, et al.
Publicado: (2018)

The Diagnostic Values of Peptidoglycan, Lipopolysaccharide, and (1,3)-Beta-D-Glucan in Patients with Suspected Bloodstream Infection: A Single Center, Prospective Study
por: Zhao, Ying, et al.
Publicado: (2022)

Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study
por: Novy, Emmanuel, et al.
Publicado: (2023)

Ultrasound Diagnosis and Follow-Up of Neonate Renal Candidiasis
por: Boulanger, Yves, et al.
Publicado: (2016)

Congenital cutaneous candidiasis in a full‐term neonate
por: Salusti‐Simpson, Michela, et al.
Publicado: (2022)

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016)

Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery
por: Szyszkowitz, Alexander, et al.
Publicado: (2018)

93. A Diagnostic Stewardship Intervention to Improve Utilization of 1,3-β-D-glucan Testing
por: Kendall, Jonathan A, et al.
Publicado: (2020)

Diagnostic Performance of Bronchoalveolar Lavage (1,3)-β-d-Glucan Assay for Pneumocystis jirovecii Pneumonia
por: Zhou, Shiwei, et al.
Publicado: (2020)

Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis
por: Dai, Zhang, et al.
Publicado: (2021)

Candidiasis caused by Candida kefyr in a neonate: Case report
por: Weichert, Stefan, et al.
Publicado: (2012)

Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
por: Cahan, Heather, et al.
Publicado: (2011)

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)

Platelet Parameters and (1, 3)-β-D-Glucan as a Diagnostic and Prognostic Marker of Invasive Fungal Disease in Preterm Infants
por: Zhao, Dongying, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fm6q0jf2i4mcqrees2e3v9h5ul